Leafceuticals is a subsidiary of Las Vegas-based Freedom Leaf. They will pay $400,000 cash and $1.8 million worth of stock to acquire Irie. Leafceuticals currently makes hemp derived CBD oils, vape products and pet chews. But it doesn’t manufacture topicals or edibles, which will change with the Irie acquisition, which gives Leafceuticals a processing plant in Oakland, California, for manufacturing its CBD line.
Leafceuticals will continue extracting CBD from hemp in Nevada but will finish processing CBD into some products in California.